A novel strategy to screen pregnant women for malaria with rapid diagnostic tests and treat the test - positive women with effective antimalarials does not lower the risk of adverse pregnancy outcomes compared with treating all pregnant women with the malaria preventive sulfadoxine - pyrimethamine (SP) in sub-Saharan Africa, according to an open label randomized trial published this week in PLOS Medicine by Feiko ter Kuile, of the Liverpool School of Tropical Medicine, and colleagues. (sciencedaily.com)
Trial 2 showed that MQ recipients had less parasitemia than placebo recipients, no difference in adverse pregnancy outcomes or in low birth weight between the two groups, and poorer tolerability in the MQ group than the placebo group. (sciencedaily.com)
Secondly, some conditions mentioned in this brochure may increase the risk of adverse pregnancy outcomes including premature labor and delivery, birth injury, and stillbirth. (pregnancyafterlosssupport.com)